Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

BACKGROUND: The presence of an oligodendroglial component within a glioblastoma multiforme (GBM) is considered a prognostically favorable factor, but the clinical outcome of patients with glioblastoma multiforme with oligodendroglial component (GBMO) after combined post-operative radiotherapy and ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Vordermark, Dirk, Ruprecht, Klemens, Rieckmann, Peter, Roggendorf, Wolfgang, Vince, Giles H, Warmuth-Metz, Monika, Kölbl, Oliver, Flentje, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1621074/
https://www.ncbi.nlm.nih.gov/pubmed/17049083
http://dx.doi.org/10.1186/1471-2407-6-247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1621074/
https://www.ncbi.nlm.nih.gov/pubmed/17049083
http://dx.doi.org/10.1186/1471-2407-6-247

Ejemplares similares